The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced this week that the impact factor of its flagship publication, The Journal of Nuclear Medicine (JNM), increased by 12 percent in 2017.
Impact factors indicate a journal’s significance within an industry by tracking citations. According to new data from Clarivate Analytics, JNM’s impact factor was 6.646 in 2016 and 7.439 in 2017. It is now No. 5 in the overall rankings for medial imaging journals.
“JNM’s increasing impact factor demonstrates the journal’s influential role in molecular imaging, and we are honored that it is the journal of choice for many distinguished researchers,” Johannes Czernin, MD, the journal’s editor-in-chief, said in a prepared statement. “Among nuclear medicine journals, JNM continues to have the highest number of citations, the highest average five-year impact factor, the highest number of citable articles, and the highest influence score.”
He also gave credit to JNM’s previous editor-in-chief, Dominique Delbeke, MD, PhD, nothing that the Clarivate Analytics data was from 2016.
“We are continuing to build on her success, focusing on providing the highest quality in basic, translational and clinical sciences,” Delbeke said in the same statement.
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.